SCHEMBL6230685

SCHEMBL6230685

N#C/C(=C\C(F)=C(\c1ccc(Cl)cc1)C1CC1)c1ccc(F)c(Oc2ccccc2)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NPSR1 Q6W5P4 1/20 0.32
MGLL Q99685 2/20 0.32
HTR1A P08908 1/20 0.31
SLC6A2 P23975 1/20 0.31
SLC6A4 P31645 1/20 0.31
SLC6A3 Q01959 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
MAPT P10636 1/20 0.31
EGFR P00533 1/20 0.31
IGF1R P08069 1/20 0.31
IGF2R P11717 1/20 0.31
ERBB2 P04626 1/20 0.30
GAA P10253 1/20 0.30
PKM P14618 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6230688 1.00 LMNA (0.34) LMNAL3MBTL1SMN1; SMN2NPSR1MGLL
SCHEMBL6932505 0.80 LMNA (0.35) LMNAL3MBTL1SMN1; SMN2NPSR1HTR1A
SCHEMBL6935659 0.80 LMNA (0.35) LMNAL3MBTL1SMN1; SMN2NPSR1HTR1A
SCHEMBL8418431 0.75 SRD5A2 (0.38) LMNAL3MBTL1SMN1; SMN2NPSR1GAA
SCHEMBL6932576 0.72 PPARA (0.35) LMNAL3MBTL1SMN1; SMN2GAAPTGDR2
SCHEMBL6932578 0.72 PPARA (0.35) LMNAL3MBTL1SMN1; SMN2GAAPTGDR2
SCHEMBL9540468 0.71 LMNA (0.36) LMNAL3MBTL1SMN1; SMN2NPSR1MGLL
SCHEMBL9540472 0.71 LMNA (0.36) LMNAL3MBTL1SMN1; SMN2NPSR1MGLL
SCHEMBL6934681 0.69 CXCL12 (0.38) HTR1ASLC6A2SLC6A4SLC6A3
SCHEMBL6934678 0.69 CXCL12 (0.38) HTR1ASLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1278720-B1 1,4-DIARYL-2-FLUORO-4-CYANO-2-BUTENES, PROCESS FOR THEIR PREPARATION AND INTERMEDIATES USEFUL THEREFOR BASF AG (DE) 2005-04-06 EP disclosed
US-20030100789-A1 Pesticides such as (R,S)-(Z)-1-(1-(p-chlorophenyl)-2-fluoro-4-(4-fluoro-3-phenoxyphenyl)-4 -cyano-2-butenyl)-cyclopropane HU YULIN (US) 2003-05-29 US disclosed
EP-1278720-A1 1,4-DIARYL-2-FLUORO-4-CYANO-2-BUTENES, PROCESS FOR THEIR PREPARATION AND INTERMEDIATES USEFUL THEREFOR BASF AKTIENGESELLSCHAFT (DE) 2003-01-29 EP disclosed
US-6444838-B2 CHEMICAL INTERMEDIATES FOR INSECTICIDES, MITICIDES BASF AKTIENGESELLSCHAFT (DE) 2002-09-03 US disclosed
US-20020019556-A1 Chemical intermediates for insecticides, miticides INTL PROP DEPT, BASF AKTIENGESELLSCHAFT (DE) 2002-02-14 US disclosed
WO-2001083428-A1 1,4-DIARYL-2-FLUORO-4-CYANO-2-BUTENES, PROCESS FOR THEIR PREPARATION AND INTERMEDIATES USEFUL THEREFOR BASF AKTIENGESELLSCHAFT (DE) 2001-11-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030100789-A1 Pesticides such as (R,S)-(Z)-1-(1-(p-chlorophenyl)-2-fluoro-4-(4-fluoro-3-phenoxyphenyl)-4 -cyano-2-butenyl)-cyclopropane DDT, CYP1B1, FAR1 LMNA 2146/4885L3MBTL1 889/4885SMN1; SMN2 3682/4885
US-20020019556-A1 Chemical intermediates for insecticides, miticides DDT, MLYCD, HADHB LMNA 2658/4885L3MBTL1 1794/4885SMN1; SMN2 3104/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.